SCHEMBL24732004

SCHEMBL24732004

c1ccc(-c2cccc(Nc3ccc(C4CCCCC4)cc3)c2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPY5R Q15761 1/20 0.50
FAAH O00519 1/20 0.47
MGLL Q99685 1/20 0.47
MEN1 O00255 5/20 0.44
KMT2A Q03164 5/20 0.44
MAPT P10636 5/20 0.44
ALDH1A1 P00352 3/20 0.44
AR P10275 1/20 0.44
POLB P06746 2/20 0.42
LMNA P02545 3/20 0.42
GAA P10253 3/20 0.42
TDP1 Q9NUW8 3/20 0.42
GFER P55789 2/20 0.42
KDM4E B2RXH2 1/20 0.42
SMN1; SMN2 Q16637 3/20 0.42
XBP1 P17861 1/20 0.42
HTT P42858 1/20 0.42
MAPK1 P28482 2/20 0.41
DGAT1 O75907 2/20 0.40
PTGES O14684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24732376 0.95 NPY5R (0.46) NPY5RFAAHMGLLMEN1KMT2A
SCHEMBL24731685 0.89 KMO (0.46) NPY5RFAAHMGLLMEN1KMT2A
SCHEMBL27199120 0.89 NPY5R (0.52) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL25906728 0.89 NPY5R (0.52) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL27199114 0.89 NPY5R (0.52) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL27199121 0.89 NPY5R (0.52) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL31347788 0.89 NPY5R (0.56) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL1335958 0.87 NPY5R (0.60) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL11199863 0.87 NPY5R (0.60) NPY5RMEN1KMT2AMAPTALDH1A1
SCHEMBL28690383 0.85 NPY5R (0.57) NPY5RMEN1KMT2AMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220320437-A1 ORGANIC COMPOUND, OLED, AND APPLICATION THEREOF WUHAN TIANMA MICROELECTRONICS CO., LTD. (CN) 2022-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220320437-A1 ORGANIC COMPOUND, OLED, AND APPLICATION THEREOF OCIAD1, OCIAD2, OSTC NPY5R 3300/4885FAAH 3729/4885MGLL 4250/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.